329 related articles for article (PubMed ID: 26508681)
21. Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients.
Tsai WC; Yang JY; Luan CC; Wang YJ; Lai YC; Liu LC; Peng YS
Clin Exp Nephrol; 2016 Oct; 20(5):815-821. PubMed ID: 26658792
[TBL] [Abstract][Full Text] [Related]
22. Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study.
Leung S; McCormick B; Wagner J; Biyani M; Lavoie S; Imtiaz R; Zimmerman D
BMC Nephrol; 2015 Dec; 16():205. PubMed ID: 26645271
[TBL] [Abstract][Full Text] [Related]
23. An Update on Phosphate Binders: A Dietitian's Perspective.
Gutekunst L
J Ren Nutr; 2016 Jul; 26(4):209-18. PubMed ID: 26920090
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of hyperphosphatemia in hemodialysis patients].
Rieu P
Nephrol Ther; 2005 Dec; 1 Suppl 4():S322-9. PubMed ID: 17373203
[TBL] [Abstract][Full Text] [Related]
25. Hyperphosphatemia in end-stage renal disease.
Indridason OS; Quarles LD
Adv Ren Replace Ther; 2002 Jul; 9(3):184-92. PubMed ID: 12203200
[TBL] [Abstract][Full Text] [Related]
26. Adherence to phosphate binder therapy is the primary determinant of hyperphosphatemia incidence in patients receiving peritoneal dialysis.
Hung KY; Liao SC; Chen TH; Chao MC; Chen JB
Ther Apher Dial; 2013 Feb; 17(1):72-7. PubMed ID: 23379497
[TBL] [Abstract][Full Text] [Related]
27. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
Chan MW; Cheah HM; Mohd Padzil MB
Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
[TBL] [Abstract][Full Text] [Related]
28. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.
Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH
Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782
[TBL] [Abstract][Full Text] [Related]
29. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling.
Debowska M; Poleszczuk J; Wojcik-Zaluska A; Ksiazek A; Zaluska W
Artif Organs; 2015 Dec; 39(12):1005-14. PubMed ID: 25994493
[TBL] [Abstract][Full Text] [Related]
30. Control of hyperphosphatemia among patients with ESRD.
Coladonato JA
J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S107-14. PubMed ID: 16251245
[TBL] [Abstract][Full Text] [Related]
31. Phosphate Binders and Targets Over Decades: Do We have it Right Now?
Marcuccilli M; Chonchol M; Jovanovich A
Semin Dial; 2017 Mar; 30(2):134-141. PubMed ID: 28064444
[TBL] [Abstract][Full Text] [Related]
32. Phosphate management in chronic kidney disease.
Bhan I
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):174-9. PubMed ID: 24445424
[TBL] [Abstract][Full Text] [Related]
33. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
34. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
Kuhlmann MK
Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
[TBL] [Abstract][Full Text] [Related]
35. Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis.
St-Jules DE; Rozga MR; Handu D; Carrero JJ
Clin J Am Soc Nephrol; 2020 Dec; 16(1):107-120. PubMed ID: 33380474
[TBL] [Abstract][Full Text] [Related]
36. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.
Locatelli F; Del Vecchio L; Violo L; Pontoriero G
Expert Opin Drug Saf; 2014 May; 13(5):551-61. PubMed ID: 24702470
[TBL] [Abstract][Full Text] [Related]
37. Are calcium-based phosphate binders ever preferable in dialysis patients?
Jain N; Reilly RF
Semin Dial; 2014; 27(3):269-72. PubMed ID: 24620781
[No Abstract] [Full Text] [Related]
38. Phosphate removal and hemodialysis conditions.
Pohlmeier R; Vienken J
Kidney Int Suppl; 2001 Feb; 78():S190-4. PubMed ID: 11169009
[TBL] [Abstract][Full Text] [Related]
39. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
40. Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients.
Imtiaz R; Hawken S; McCormick BB; Leung S; Hiremath S; Zimmerman DL
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
